NIH-funded research R21 grant

MN1 gene role in brain malformations and developmental disorders

Official title: Investigating the role of MN1 in CNS developmental malformations

Funded at Seattle Children's Hospital · NIH-11499083 · Data updated 2026-11-12

Researchers will study how MN1 mutations affect brain development to understand conditions like PMG, RES, autism, and related IDD.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$516,175
NIH project number1R21NS152673-01
Project IDNIH-11499083 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include patients with MN1-related developmental disorders or those affected by PMG or RES in the future, who may benefit from advances in diagnosis or therapy.

Less likely to help

Individuals without MN1-related conditions may not directly benefit from this basic research.

What this research studies

This project compares mouse models with Mn1 null and C-terminal truncation mutations to learn how MN1 shapes brain development. By examining the cerebellum and cerebral cortex in these mice, scientists aim to uncover the developmental programs that go awry in MN1-related brain malformations. The work uses genetically engineered mice and analyzes brain structure, gene expression, and neural development processes to connect MN1 dysfunction with human neurodevelopmental disorders. Insights could inform future strategies for diagnosis or targeted therapies in conditions associated with MN1 mutations.

Why it matters

Potential benefit: Better understanding of MN1-related brain malformations could lead to earlier diagnosis and new directions for treatments or interventions for affected individuals.

How similar studies have gone: Previous mouse model studies have begun to reveal MN1's role in brain development, with some findings aligning to human neurodevelopmental phenotypes, but this specific truncation model is novel.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Millen, Kathleen Joyce — Seattle Children's Hospital
  • Study coordinator: Millen, Kathleen Joyce

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.